Previous Page  2 / 21 Next Page
Information
Show Menu
Previous Page 2 / 21 Next Page
Page Background

Page 16

Notes:

August 17-18, 2017 | Toronto, Canada

ANNUAL BIOTECHNOLOGY CONGRESS

allied

academies

Ann Biol Sci, 2017

ISSN: 2348-1927

M

y laboratory discovered that some bovine antibodies

are the largest known to exist in a species. This is

because of generation of an exceptionally long CDR3H

(up to 61 amino acids) which is encoded by an unusually

long germline IGHD genes together with an unique

insertion of “A” nucleotide rich conserved short nucleotide

sequence at the IGHV-IGHD junction. The atypical CDR3H

provides a “knob and stalk” structure capable of creating

configurational diversity via variable intra-CDR3H disulfide

bridges within the knob. The knob is held by the solvent

exposed stalk formed by anti-parallel beta strands. I have

exploited these structural features of the bovine antibody for

the development of new therapeutics and vaccines. In this

context, I will provide insights into the structural optimization

of anti-viral bovine scFv to enhance their potency, apart

from discussing influence of framework residues on viral

neutralization function. I will provide ‘proof of concept’ for

developing new vaccines by antigenizing bovine antibody

with exceptionally long CDR3H that induce specific immune

response. First, I successfully developed functional bovine

scFv with an exceptionally long CDR3H followed by grafting

of a viral B-epitope into the CDR3H. The grafted B-epitope

in the exceptionally long CDR3H of bovine scFv sustained its

native configuration and induced desired specific antibody

response. Thus, antigenization of bovine scFv with an

exceptionally long CDR3H provides a novel approach to

developing new vaccines against infectious disease.

Speaker Biography

Azad K Kaushik has published two books

Molecular Immunobiology of Self-Reactivity

(1992) and

Comparative Immunoglobulin Genetics

(2014) and over 87 research arti-

cles. He is on the editorial boards of several immunology journals and is a Consultant

to various international organizations. He was recognized as The Esther Z Greenberg

Honors Chair in Biomedical Research, and Visiting Professor, Oklahoma Medical Re-

search Foundation, USA, in 1998. He received BVSc&AH (Honors) in 1976 and MVSc

(1978) from the Faculty of Veterinary Science, Hisar, Haryana, India; followed by Doc-

teur es Science (DSc) in Immunology (1987) from the Pasteur Institute (University of

Paris VII), Paris, France. He has been teaching Immunology at the University of Guelph

since 1991.

e:

akaushik@uoguelph.ca

Azad K Kaushik

University of Guelph, Canada

Developing novel vaccines for neonatal immunization

Azad K Kaushik, Ann Biol Sci, 2017, 5:3

DOI: 10.21767/2348-1927-C1-002